Bovine Blood Plasma Derivatives Market

Bovine Blood Plasma Derivatives Market (Derivative Type: Immunoglobulin, Fibrinogen, Bovine Serum Albumin, Fetal Bovine Serum, Thrombin, Transferrin, Newborn Calf Serum, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2031

Global Bovine Blood Plasma Derivatives Market Outlook 2031

  • The industry was valued at US$ 1.9 Bn in 2022
  • It is estimated to grow at a CAGR of 5.7% from 2023 to 2031 and reach US$ 3.2 Bn by the end of 2031

Analyst Viewpoint

Expansion in animal feed sector and rise in production of vaccines and immunoglobulins are propelling the bovine blood plasma derivatives market size. Bovine blood products are gaining traction in the food & beverage sector for the production of various functional foods and dietary supplements. They are also widely employed in the R&D of various diagnostic tests.

Thrombin derivatives are gaining popularity in vitro studies, coagulation research, protein structure analysis, medical research, and biochemical research, whereas bovine-derived albumins are being widely used in the production of several vaccines. Major vendors in the industry are adopting M&A strategies to strengthen their product portfolio and increase their bovine blood plasma derivatives market share.

Bovine Blood Plasma Derivatives Market

Market Introduction

Bovine blood plasma derivatives are products derived from the blood of cattle. These derivatives are used in various applications such as food processing, biopharmaceuticals, and animal feed. Immunoglobulin, fibrinogen, bovine serum albumin, fetal bovine serum, thrombin, transferrin, and newborn calf serum are various types of bovine blood plasma derivatives. Bovine immunoglobulin G (IgG) is one of the most common commercially available bovine-derived protein fractions.

Bovine blood plasma protein extraction involves the use of a chromatographic extraction process that does not involve the use of heat, organic solvents, or stabilizers. Bovine serum derivatives are in high demand across various end-use industries such as nutrition supplements, diagnostics, pharmaceuticals, biotechnology, cosmetics, and food & beverage. These derivatives are considered a rich protein source.

Expansion in Animal Feed Sector Fueling Bovine Blood Plasma Derivatives Market Value

Bovine blood-derived proteins are used in the production of plasma powder that are highly digestible animal protein sources used to improve feed palatability and gut health in animals. Spray-dried plasma proteins are a good protein source for dairy cows. These proteins help improve milk production significantly without affecting cow’s reproductive performance and health. Spray-dried bovine plasma and hydrolyzed spray-dried bovine plasma sources also aid in increasing pig growth performance and reduce diarrhea in the post-weaning period.

Growth in the animal feed sector is propelling the bovine blood plasma derivatives market development. According to an Institute for Feed Education and Research (IFEEDER) study, pets and domestic livestock in the U.S. consumed approximately 284 million tons of animal food in 2019. The top three feed consumers included beef cattle at 64.5 million tons, hogs at 61.8 million tons, and broiler chickens at 60.8 million tons. Moreover, rise in number of animal feedstock is expected to spur the bovine blood plasma derivatives industry growth in the near future. According to Alltech's 2021 Global Feed Survey, global animal feed production increased 1% in 2020 to 1,187.7 million metric tons.

Major companies in the food & beverage industry are launching new functional foods and dietary supplements. They are incorporating blood plasma derivatives to advance the nutritional values of their products. Blood proteins show good functional properties making them suitable for use in processed food for human consumption. Recent advancements in blood collection and processing techniques have led to a surge in the adoption of blood protein ingredients in foods and dietary supplements. Plasma proteins can be very effective low-cost alternatives for replacing eggs in baked goods. Blood proteins provide an economic and readily available alternative source of proteins and irons for use in foods and dietary supplements. Thus, surge in demand for functional foods and dietary supplements is augmenting the bovine blood plasma derivatives market progress.

Rise in Production of Vaccines and Immunoglobulins Driving Market Expansion

Immunoglobulins can be employed in the treatment and management of various gastrointestinal diseases. Various studies have demonstrated the effectiveness of serum-derived bovine immunoglobulin/protein isolate in reducing diarrhea and restoring the ability of the gastrointestinal tract to properly absorb and utilize nutrients. Bovine immunoglobulins can also be used for passive immunization in humans. These immunoglobulins can also be incorporated into vaccines designed for specific pathogens, providing a targeted approach to disease prevention.

Bovine blood plasma derivatives are gaining traction in the R&D of various diagnostic tests. Thrombin is gaining popularity across the healthcare sector as it is widely used in various diagnostic procedures and surgeries. It is often used in conjunction with other hemostatic aids, including absorbable agents, and with fibrinogen in fibrin glues. Bovine blood plasma derivatives find extensive applications in various research activities including coagulation research, vitro study, medical research, biochemical research, and protein structure analysis. Hence, R&D of diagnostic tests is fueling the bovine blood plasma derivatives market landscape.

High Demand for Thrombin Derivatives

According to the latest bovine blood plasma derivatives market trends, the thrombin derivative type segment is projected to hold largest share during the forecast period. Growth of the segment can be ascribed to increase in usage of thrombin during surgeries and diagnostic purposes. R&D applications of thrombin include in vitro studies, coagulation research, protein structure analysis, medical research, and biochemical research.

According to the latest bovine blood plasma derivatives market research, the bovine serum albumin segment is expected to maintain its position as the second leading segment in the near future. Bovine serum albumin is widely employed in the food sector, drug formulation, and as a component of media for cell culture. Bovine-derived albumins are used in the production of several vaccines. They are utilized as a standard for protein concentrations (Bradford protein assay) in cell culture protocols.

Regional Outlook

According to the latest bovine blood plasma derivatives market analysis, North America held largest share in 2022, followed by Asia Pacific. High demand for pharmaceuticals and biotechnology products is driving the market dynamics in North America. Research and development activities related to medical products and biotechnology are also boosting the demand for bovine blood plasma derivatives in the region.

Growth in animal husbandry sector is propelling the bovine blood plasma derivatives market statistics in Asia Pacific. The total meat production in India was 9.29 million tons in 2022, an increase of 5.62% as compared to 2021, according to the ‘Basic Animal Husbandry Statistics,’ prepared by the Ministry of Fisheries, Animal Husbandry & Dairying, Government of India. Moreover, India continued to remain the largest milk-producing country in the world. The production increased by 5.29% in 2022 over the previous year.

Analysis of Key Players in Bovine Blood Plasma Derivatives Market

Most blood plasma derivative companies are acquiring other globally recognized biotechnology businesses to strengthen their product portfolio. Some of the key bovine blood plasma derivative manufacturers include Merck KGaA, LAMPIRE Biological Laboratories, Inc., Proliant Health & Biologicals, Rocky Mountain Biologicals, Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc., Kraeber & Co GmbH, Auckland BioSciences Ltd., and Lake Immunogenics, Inc.

These companies have been profiled in the bovine blood plasma derivatives market report based on parameters, such as business strategies, financial overview, product portfolio, company overview, recent developments, and business segments.

Key Developments

  • In April 2022, ANZCO Foods, the parent company of Bovogen Biologicals, entered into an agreement to acquire the globally recognized biotechnology business Moregate Biotech, further strengthening its capacity in the healthcare sector
  • In September 2021, Auckland BioSciences acquired CellSera, an Australia-based serum company. CellSera specializes in fetal bovine serum.

Bovine Blood Plasma Derivatives Market Snapshot

Attribute Detail
Market Size in 2022 US$ 1.9 Bn
Market Forecast (Value) in 2031 US$ 3.2 Bn
Growth Rate (CAGR) 5.7%
Forecast Period 2023-2031
Historical Data Available for 2021
Quantitative Tons US$ Bn for Value and Kilograms for Volume
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Derivative Type
    • Immunoglobulin
    • Fibrinogen
    • Serum Albumin
    • Fetal Bovine Serum
    • Thrombin
    • Transferrin
    • Newborn Calf Serum
    • Others (BGG, etc.)
  • Application
    • Pharmaceutical Industry
    • Diagnostics Industry
    • Cell Culture/ Biotechnology
    • Research and Development
    • Food Industry
    • Cosmetic Industry
    • Others (Nutrition Supplements, etc.)
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • France
  • U.K.
  • Italy
  • Russia & CIS
  • China
  • India
  • Japan
  • ASEAN
  • Brazil
  • Mexico
  • GCC
  • South Africa
Companies Profiled
  • Merck KGaA
  • LAMPIRE Biological Laboratories, Inc.
  • Proliant Health & Biologicals
  • Rocky Mountain Biologicals
  • Bovogen Biologicals Pty Ltd.
  • Thermo Fisher Scientific, Inc.
  • Kraeber & Co GmbH
  • Auckland BioSciences Ltd.
  • Lake Immunogenics, Inc.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the bovine blood plasma derivatives market in 2022?

It was valued at US$ 1.9 Bn in 2022

How is the bovine blood plasma derivatives industry expected to grow by 2031?

It is projected to grow at a CAGR of 5.7% from 2023 to 2031

What are the key factors driving the demand for bovine blood plasma derivatives?

Expansion in animal feed sector and rise in production of vaccines and immunoglobulins

Which bovine blood plasma derivatives segment held the largest share in 2022?

The thrombin derivative type segment held the largest share in 2022

Which region was the most lucrative in the bovine blood plasma derivatives business in 2022?

North America was the most lucrative region in 2022

Who are the prominent bovine blood plasma derivative manufacturers?

Merck KGaA, LAMPIRE Biological Laboratories, Inc., Proliant Health & Biologicals, Rocky Mountain Biologicals, Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc., Kraeber & Co GmbH, Auckland BioSciences Ltd., and Lake Immunogenics, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Bovine Blood Plasma Derivatives Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Derivative Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Derivative Type, 2017–2031

            6.3.1. Immunoglobulin

            6.3.2. Fibrinogen

            6.3.3. Bovine Serum Albumin

            6.3.4. Fetal Bovine Serum

            6.3.5. Thrombin

            6.3.6. Transferrin

            6.3.7. Newborn Calf Serum

            6.3.8. Others

        6.4. Market Attractiveness Analysis, by Derivative Type

    7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Pharmaceutical Industry

            7.3.2. Diagnostics Industry

            7.3.3. Cell Culture/ Biotechnology

            7.3.4. Research and Development

            7.3.5. Food Industry

            7.3.6. Cosmetic Industry

            7.3.7. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region, 2017–2031

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Bovine Blood Plasma Derivatives Market Analysis and Forecast

        9.1. Introduction

        9.2. Key Findings

        9.3. Market Value Forecast, by Derivative Type, 2017–2031

            9.3.1. Immunoglobulin

            9.3.2. Fibrinogen

            9.3.3. Bovine Serum Albumin

            9.3.4. Fetal Bovine Serum

            9.3.5. Thrombin

            9.3.6. Transferrin

            9.3.7. Newborn Calf Serum

            9.3.8. Others

        9.4. Market Value Forecast, by Application, 2017–2031

            9.4.1. Pharmaceutical Industry

            9.4.2. Diagnostics Industry

            9.4.3. Cell Culture/ Biotechnology

            9.4.4. Research and Development

            9.4.5. Food Industry

            9.4.6. Cosmetic Industry

            9.4.7. Others

        9.5. Market Value Forecast, by Country, 2017–2031

            9.5.1. U.S.

            9.5.2. Canada

        9.6. Market Attractiveness Analysis

            9.6.1. By Derivative Type

            9.6.2. By Application

            9.6.3. By Country

    10. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Derivative Type, 2017–2031

            10.3.1. Immunoglobulin

            10.3.2. Fibrinogen

            10.3.3. Bovine Serum Albumin

            10.3.4. Fetal Bovine Serum

            10.3.5. Thrombin

            10.3.6. Transferrin

            10.3.7. Newborn Calf Serum

            10.3.8. Others

        10.4. Market Value Forecast, by Application, 2017–2031

            10.4.1. Pharmaceutical Industry

            10.4.2. Diagnostics Industry

            10.4.3. Cell Culture/ Biotechnology

            10.4.4. Research and Development

            10.4.5. Food Industry

            10.4.6. Cosmetic Industry

            10.4.7. Others

        10.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.5.1. Germany

            10.5.2. U.K.

            10.5.3. France

            10.5.4. Italy

            10.5.5. Spain

            10.5.6. Rest of Europe

        10.6. Market Attractiveness Analysis

            10.6.1. By Derivative Type

            10.6.2. By Application

            10.6.3. By Country/Sub-region

    11. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Derivative Type, 2017–2031

            11.3.1. Immunoglobulin

            11.3.2. Fibrinogen

            11.3.3. Bovine Serum Albumin

            11.3.4. Fetal Bovine Serum

            11.3.5. Thrombin

            11.3.6. Transferrin

            11.3.7. Newborn Calf Serum

            11.3.8. Others

        11.4. Market Value Forecast, by Application, 2017–2031

            11.4.1. Pharmaceutical Industry

            11.4.2. Diagnostics Industry

            11.4.3. Cell Culture/ Biotechnology

            11.4.4. Research and Development

            11.4.5. Food Industry

            11.4.6. Cosmetic Industry

            11.4.7. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. China

            11.5.2. Japan

            11.5.3. India

            11.5.4. Australia & New Zealand

            11.5.5. Rest of Asia Pacific

        11.6. Market Attractiveness Analysis

            11.6.1. By Derivative Type

            11.6.2. By Application

            11.6.3. By Country/Sub-region

    12. Latin America Bovine Blood Plasma Derivatives Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Derivative Type, 2017–2031

            12.3.1. Immunoglobulin

            12.3.2. Fibrinogen

            12.3.3. Bovine Serum Albumin

            12.3.4. Fetal Bovine Serum

            12.3.5. Thrombin

            12.3.6. Transferrin

            12.3.7. Newborn Calf Serum

            12.3.8. Others

        12.4. Market Value Forecast, by Application, 2017–2031

            12.4.1. Pharmaceutical Industry

            12.4.2. Diagnostics Industry

            12.4.3. Cell Culture/ Biotechnology

            12.4.4. Research and Development

            12.4.5. Food Industry

            12.4.6. Cosmetic Industry

            12.4.7. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. Brazil

            12.5.2. Mexico

            12.5.3. Rest of Latin America

        12.6. Market Attractiveness Analysis

            12.6.1. By Derivative Type

            12.6.2. By Application

            12.6.3. By Country/Sub-region

    13. Middle East & Africa Bovine Blood Plasma Derivatives Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Derivative Type, 2017–2031

            13.3.1. Immunoglobulin

            13.3.2. Fibrinogen

            13.3.3. Bovine Serum Albumin

            13.3.4. Fetal Bovine Serum

            13.3.5. Thrombin

            13.3.6. Transferrin

            13.3.7. Newborn Calf Serum

            13.3.8. Others

        13.4. Market Value Forecast, by Application, 2017–2031

            13.4.1. Pharmaceutical Industry

            13.4.2. Diagnostics Industry

            13.4.3. Cell Culture/ Biotechnology

            13.4.4. Research and Development

            13.4.5. Food Industry

            13.4.6. Cosmetic Industry

            13.4.7. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. GCC Countries

            13.5.2. South Africa

            13.5.3. Rest of Middle East & Africa

        13.6. Market Attractiveness Analysis

            13.6.1. By Derivative Type

            13.6.2. By Application

            13.6.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        14.2. Market Share Analysis, by Company (2022)

        14.3. Company Profiles

            14.3.1. Merck KGaA

                14.3.1.1. Company Overview

                14.3.1.2. Product Portfolio

                14.3.1.3. SWOT Analysis

                14.3.1.4. Financial Overview

                14.3.1.5. Strategic Overview

            14.3.2. LAMPIRE Biological Laboratories, Inc.

                14.3.2.1. Company Overview

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Financial Overview

                14.3.2.5. Strategic Overview

            14.3.3. Proliant Health & Biologicals

                14.3.3.1. Company Overview

                14.3.3.2. Product Portfolio

                14.3.3.3. SWOT Analysis

                14.3.3.4. Financial Overview

                14.3.3.5. Strategic Overview

            14.3.4. Rocky Mountain Biologicals

                14.3.4.1. Company Overview

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Financial Overview

                14.3.4.5. Strategic Overview

            14.3.5. Bovogen Biologicals Pty Ltd.

                14.3.5.1. Company Overview

                14.3.5.2. Product Portfolio

                14.3.5.3. SWOT Analysis

                14.3.5.4. Financial Overview

                14.3.5.5. Strategic Overview

            14.3.6. Thermo Fisher Scientific, Inc.

                14.3.6.1. Company Overview

                14.3.6.2. Product Portfolio

                14.3.6.3. SWOT Analysis

                14.3.6.4. Financial Overview

                14.3.6.5. Strategic Overview

            14.3.7. Kraeber & Co GmbH

                14.3.7.1. Company Overview

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

                14.3.7.4. Financial Overview

                14.3.7.5. Strategic Overview

            14.3.8. Auckland BioSciences Ltd.

                14.3.8.1. Company Overview

                14.3.8.2. Product Portfolio

                14.3.8.3. SWOT Analysis

                14.3.8.4. Financial Overview

                14.3.8.5. Strategic Overview

            14.3.9. Lake Immunogenics, Inc.

                14.3.9.1. Company Overview

                14.3.9.2. Product Portfolio

                14.3.9.3. SWOT Analysis

                14.3.9.4. Financial Overview

                14.3.9.5. Strategic Overview

    List of Tables

    Table 01: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

    Table 02: Global Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

    Table 03: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 04: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 05: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

    Table 07: North America Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

    Table 08: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 09: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 10: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 11: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

    Table 12: Europe Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

    Table 13: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 14: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 15: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 16: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

    Table 17: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

    Table 18: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 19: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 21: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

    Table 22: Latin America Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

    Table 23: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 25: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 26: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

    Table 27: Middle East & Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

    Table 28: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 29: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 30: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

    Figure 03: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

    Figure 04: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application 2022 and 2031

    Figure 05: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 06: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 07: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 08: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Region, 2022 and 2031

    Figure 09: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Region, 2023–2031

    Figure 10: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

    Figure 11: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

    Figure 12: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

    Figure 13: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 14: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 15: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 16: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 17: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country, 2022 and 2031

    Figure 18: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country, 2023–2031

    Figure 19: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

    Figure 20: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

    Figure 21: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

    Figure 22: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 23: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 24: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 25: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 26: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 27: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 28: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

    Figure 29: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

    Figure 30: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

    Figure 31: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application 2022 and 2031

    Figure 32: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 33: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 34: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 35: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 36: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 37: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

    Figure 38: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

    Figure 39: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

    Figure 40: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 41: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 42: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 43: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 44: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 45: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 46: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

    Figure 47: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

    Figure 48: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

    Figure 49: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 50: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 51: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

    Figure 52: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

    Figure 53: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 54: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 55: Global Africa Bovine Blood Plasma Derivatives Market Share Analysis, by Company, 2022

Copyright © Transparency Market Research, Inc. All Rights reserved